| CSVD group (n = 24) | Control group(n = 21) | P |
---|---|---|---|
Sex (male / famale) | 15/9 | 8/13 | 0.102 |
Age, years, median (IQR) | 63.5 (60.8,69.0) | 69.0 (68.0,70.0) | 0.014* |
Hypertension, n(%) | 21 (87.5) | 6 (28.6) | < 0.001* |
DM, n(%) | 5 (20.8) | 2 (9.5) | 0.527 |
History of symptomatic stroke, n(%) | 11 (45.8) | 0 (0.0) | < 0.001* |
Hyperlipidemia, n(%) | 21 (87.5) | 4 (19.0) | < 0.001* |
Smoking history, n(%) | 5 (20.8) | 1 (4.8) | 0.253 |
Presence of lacunar infarcts, n(%) | 9 (37.5) | 0 (0.0) | 0.006* |
Extensive WMHa, n(%) | 22 (91.7) | 0 (0.0) | < 0.001* |
Moderate to extensive EPVSs in basal gangliab, n(%) | 18 (75.0) | 0 (0.0) | < 0.001* |
Presence of cerebral microbleeds, n(%) | 22 (91.7) | 0 (0.0) | < 0.001* |
Total CSVD burden, n(%) | |||
 1 | 0 (0.0) | 0 (0.0) | – |
 2 | 4 (16.7) | 0 (0.0) | 0.151 |
 3 | 10 (41.7) | 0 (0.0) | 0.003* |
 4 | 10 (41.7) | 0 (0.0) | 0.003* |
PSQI, median (IQR) | 5.5 (3.0,9.3) | 6.0 (4.0,9.0) | 0.515 |
BMI, kg/m2, median (IQR) | 24.1 (22.3,27.8) | 22.4 (20.8,25.4) | 0.125 |
AHI, times/hour, median (IQR) | 19.4(12.1, 27.8) | 9.5(6.6, 16.6) | 0.004* |
PLMI during sleep period, times/hour, median (IQR) | 1.8(0.0, 16.4) | 0.4(0.0, 12.4) | 0.591 |
Average HR during the sleep period, times/min, median (IQR) | 65.5 (60.8,72.5) | 63.0 (57.0,69.0) | 0.127 |
HRV during awake period, median (IQR) | |||
 SDNN | 70.7 (61.2, 86.5) | 78.5 (64.0, 80.8) | 0.585 |
 RMSSD | 28.7(19.3, 41.8) | 29.7(25.2, 44.3) | 0.381 |
 PNN50 | 3.1(0.9, 9) | 7.5(3.8, 16.6) | 0.024* |
 LF/HF | 1.4(1.0, 2.0) | 1.2(0.9, 1.5) | 0.231 |
HRV during sleep period, median (IQR) | |||
 SDNN | 53.9 (45.7,64.0) | 69.6 (49.4,74.2) | 0.009* |
 RMSSD | 26.4(19.4, 41.8) | 29.3(24.7, 43.5) | 0.260 |
 PNN50 | 2.9(1.0, 9.3) | 7.4(4.2, 19.1) | 0.006* |
 LF/HF | 1.2(0.9, 1.8) | 1.0(0.8, 1.2) | 0.144 |